Marijuana may be behind 30 PERCENT of schizophrenia cases in young men
The National Institute on Drug Abuse, which funded the study, said the results called for 'urgent action' and called on people in the US to think twice before picking up a joint. (Source: the Mail online | Health)
Source: the Mail online | Health - May 4, 2023 Category: Consumer Health News Source Type: news
Heavy Marijuana Use Increases Schizophrenia in Men, Study Finds
(Source: Reuters: Health)
Source: Reuters: Health - May 4, 2023 Category: Consumer Health News Source Type: news
Young men at highest risk of schizophrenia linked with cannabis use disorder
NIH study highlights the need to proactively screen for, prevent, and treat cannabis use disorder especially among young people. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - May 4, 2023 Category: American Health Source Type: news
Young men at highest risk of schizophrenia linked with cannabis use disorder
NIH study highlights the need to proactively screen for, prevent, and treat cannabis use disorder especially among young people (Source: NIDA News)
Source: NIDA News - May 4, 2023 Category: Addiction Tags: Addiction Science, Brain, College-Age and Young Adults, Health and Medical Professionals, Marijuana, Men, People with Drug Use Disorders, Researchers, Young Adults, News Release Source Type: news
Vanda Sues US Government Over Drug Trade Secrets Vanda Sues US Government Over Drug Trade Secrets
The company has sued the federal government over accusations that the FDA passed trade secrets about its schizophrenia drug Fanapt and sleep-disorder medication Hetlioz to generic competitors.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 3, 2023 Category: Consumer Health News Tags: Internal Medicine News Source Type: news
Cochrane Lifetime and Emeritus Members
Cochrane is proud to announce new lifetime and emeritus memberships,recognizing the extraordinary contributions of individuals who have made an exceptional, long-standing contribution to Cochrane ’s work and leadership.Cochrane ' s strength is in its collaborative, global community. Over the last 30 years, our members and supporters from more than 130 countries have worked together to produce credible, accessible health information and help inform health decision-making. Though we are spread out across the globe, our shared passion for health evidence unites us.Cochrane ’s Membership schemehelps reward everyone who hel...
Source: Cochrane News and Events - May 3, 2023 Category: Information Technology Authors: Muriah Umoquit Source Type: news
FDA OKs New LAIs for Schizophrenia; Largest Psych Fellow Class; Quelling Loneliness
(MedPage Today) -- The FDA approved a long-acting injection of risperidone (Uzedy) for the treatment of schizophrenia in adults, Teva and MedinCell announced.
And the agency approved a long-acting injectable version of aripiprazole (Abilify Asimtufii... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - May 3, 2023 Category: Psychiatry Source Type: news
Does a history of cannabis use influence onset and course of schizophrenia? - Allebeck P, Gunnarsson T, Lundin A, L öfving S, Dal H, Zammit S.
INTRODUCTION: While evidence strongly supports a causal effect of cannabis on psychosis, it is less clear whether the symptom pattern, clinical course, and outcomes differ in cases of schizophrenia with and without a background of cannabis use. MET... (Source: SafetyLit)
Source: SafetyLit - April 29, 2023 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
FDA Approves Abilify Asimtufii (aripiprazole) for the Treatment of Schizophrenia or Maintenance Monotherapy Treatment of Bipolar I Disorder in Adults
April 28, 2023 -- Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Lundbeck Pharmaceuticals LLC (Lundbeck) announce the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Abilify Asimtufii® (aripiprazole)... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 28, 2023 Category: Drugs & Pharmacology Source Type: news
FDA Approves Uzedy (risperidone) Extended-Release Injectable Suspension for the Treatment of Schizophrenia in Adults
PARSIPPANY, N.J., TEL AVIV& PARIS, April 28, 2023– Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced today that the U.S. Food and Drug... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 28, 2023 Category: Drugs & Pharmacology Source Type: news
Sleep problems, suicidal ideation, and psychopathology in first-episode psychosis - Ayers N, McCall WV, Miller BJ.
BACKGROUND AND HYPOTHESIS: Insomnia occurs frequently in the clinical course of schizophrenia. A growing literature has found associations between insomnia, suicidal ideation and behavior, and psychopathology in schizophrenia. We explored associations betw... (Source: SafetyLit)
Source: SafetyLit - April 25, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
Correlation between aggressive behavior and impulsive and aggressive personality traits in stable patients with schizophrenia - Gao L, Yang R, Fan HZ, Wang LL, Zhao YL, Tan SP, Xiao CL, Zhou SJ.
PURPOSE: To explore the correlation between aggressive behavior and impulsive and aggressive personality traits in inpatients with schizophrenia. METHODS: In total, 367 inpatients with schizophrenia were divided into two groups: the aggressive grou... (Source: SafetyLit)
Source: SafetyLit - April 24, 2023 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news
A comparison between auditory hallucinations, interpretation of voices, and formal thought disorder in dissociative identity disorder and schizophrenia spectrum disorders - Dorahy MJ, Nesbit A, Palmer R, Wiltshire B, Cording JR, Hanna D, Seager L, Middleton W.
OBJECTIVES: Dissociative identity disorder (DID) and schizophrenia-spectrum disorders (SSD) share some overlapping phenomenological features making accurate diagnosis more difficult. Childhood abuse and depersonalization have been associated with psychotic... (Source: SafetyLit)
Source: SafetyLit - April 21, 2023 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news
Erratic Sleep Tied to Worsening Schizophrenia Symptoms Erratic Sleep Tied to Worsening Schizophrenia Symptoms
Are the monotonous routines of residential facilities worsening negative symptoms for some patients with schizophrenia? Investigators suspect so.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 20, 2023 Category: Consumer Health News Tags: Psychiatry News Source Type: news
Neural, Vascular Integrity of Retina Differs in Schizophrenia
THURSDAY, April 20, 2023 -- Patients with schizophrenia have measurable differences in neural and vascular integrity of the retina, according to a study published online March 22 in JAMA Psychiatry.
Siegfried K. Wagner, M.D., from the NIHR... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 20, 2023 Category: Pharmaceuticals Source Type: news
